| # | Title | Journal | Year | Citations |
|---|
| 1 | Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study | Clinical Infectious Diseases | 2015 | 130 |
| 2 | Prognostic impact of extranodal involvement in diffuse large B‐cell lymphoma in the rituximab era | Cancer | 2012 | 79 |
| 3 | Central nervous system event in patients with diffuse large B‐cell lymphoma in the rituximab era | Cancer Science | 2012 | 73 |
| 4 | Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group | Biology of Blood and Marrow Transplantation | 2018 | 57 |
| 5 | Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2016 | 56 |
| 6 | Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B‐cell lymphoma in the rituximab era | European Journal of Haematology | 2014 | 55 |
| 7 | High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Elderly Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma: A Nationwide Retrospective Study | Biology of Blood and Marrow Transplantation | 2014 | 45 |
| 8 | Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan | Haematologica | 2014 | 44 |
| 9 | Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements | Modern Pathology | 2018 | 42 |
| 10 | High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma | Blood Cancer Journal | 2015 | 40 |
| 11 | Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL) | Annals of Oncology | 2015 | 37 |
| 12 | Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil | Bone Marrow Transplantation | 2017 | 37 |
| 13 | A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma | Oncologist | 2017 | 35 |
| 14 | Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma | Cancer Science | 2017 | 29 |
| 15 | Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy | Leukemia Research | 2015 | 28 |
| 16 | Serum ferritin level is a prognostic marker in patients with peripheral T‐cell lymphoma | International Journal of Laboratory Hematology | 2017 | 24 |
| 17 | Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancer | Medicine (United States) | 2019 | 24 |
| 18 | SIL index, comprising stage, soluble interleukin‐2 receptor, and lactate dehydrogenase, is a useful prognostic predictor in diffuse large B‐cell lymphoma | Cancer Science | 2012 | 23 |
| 19 | Prognostic significance of programmed cell death‐1‐positive cells in follicular lymphoma patients may alter in the rituximab era | European Journal of Haematology | 2013 | 23 |
| 20 | Post-therapy 18F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma | Annals of Hematology | 2015 | 23 |
| 21 | Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone | Leukemia and Lymphoma | 2015 | 22 |
| 22 | DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study | Haematologica | 2020 | 21 |
| 23 | Well‐differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: A case report | Pathology International | 2013 | 19 |
| 24 | Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin | Annals of Hematology | 2019 | 19 |
| 25 | Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone | Leukemia Research | 2013 | 17 |
| 26 | Clinical features of extranodal marginal zone lymphoma of mucosa‐associated lymphoid tissue | Hematological Oncology | 2012 | 15 |
| 27 | Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type | Medical Oncology | 2014 | 15 |
| 28 | The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis | Leukemia and Lymphoma | 2018 | 15 |
| 29 | MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy | Cancer Science | 2013 | 13 |
| 30 | Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study | Leukemia and Lymphoma | 2014 | 13 |
| 31 | A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey | International Journal of Hematology | 2016 | 13 |
| 32 | Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma | Journal of Clinical and Experimental Hematopathology: JCEH | 2013 | 12 |
| 33 | Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy | Medical Oncology | 2014 | 12 |
| 34 | Biweekly THP‐COP therapy for newly diagnosed peripheral T‐cell lymphoma patients | Hematological Oncology | 2015 | 12 |
| 35 | Clinicopathological analysis of mediastinal large B-cell lymphoma and classical Hodgkin lymphoma of the mediastinum | Leukemia and Lymphoma | 2013 | 11 |
| 36 | The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma | Leukemia and Lymphoma | 2016 | 10 |
| 37 | Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy | Leukemia Research | 2015 | 9 |
| 38 | Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis. | Blood | 2012 | 9 |
| 39 | Clinical manifestations of primary pulmonary extranodal marginal zone lymphoma of mucosa‐associated lymphoid tissue in Japanese population | Hematological Oncology | 2013 | 8 |
| 40 | Successful disease control withl-asparaginase monotherapy for aggressive natural killer cell leukemia with severe hepatic failure | Leukemia and Lymphoma | 2013 | 8 |
| 41 | A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort | Biology of Blood and Marrow Transplantation | 2020 | 8 |
| 42 | Retrospective Study of the Utility of FLIPI/FLIPI-2 for Follicular Lymphoma Patients Treated with R-CHOP | Journal of Clinical and Experimental Hematopathology: JCEH | 2012 | 7 |
| 43 | Upfront Autologous Stem Cell Transplantation for Untreated High-Risk Diffuse Large B-Cell Lymphoma in Patients Up to 60 Years of Age | Clinical Lymphoma, Myeloma and Leukemia | 2013 | 7 |
| 44 | Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma | Bone Marrow Transplantation | 2015 | 7 |
| 45 | Concentrated Ascites Reinfusion Therapy for Sinusoidal Obstructive Syndrome After Hematopoietic Stem Cell Transplantation | Artificial Organs | 2013 | 6 |
| 46 | Pharmacokinetics, safety, and efficacy of FOLFIRI plus bevacizumab in Japanese colorectal cancer patients with UGT1A1 gene polymorphisms | Journal of Clinical Pharmacology | 2014 | 6 |
| 47 | Post-treatment PET–CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass | Indian Journal of Hematology and Blood Transfusion | 2015 | 6 |
| 48 | Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the rectum: a case report | Clinical Journal of Gastroenterology | 2017 | 6 |
| 49 | Novel Prognostic Model Of Primary Mediastinal Large B-Cell Lymphoma (PMBL): A Multicenter Cooperative Retrospective Study In Japan | Blood | 2013 | 6 |
| 50 | Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia | International Journal of Hematology | 2013 | 5 |
